Drug factory · FDA FEI 3009592290

Rafarm S.A.

Thesi Pousi-Hatzi Agiou Louka, Paiania, Greece

Greece: 1

Problems found, fixed voluntarily at FDA's last inspection, Jun 21, 2024.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

5 drug inspections on record since 2018: 2 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
Brimonidine and TimololMakes it Upsher-Smith Laboratories, Inc. 0832-1425
DifluprednateMakes it Upsher-Smith Laboratories, Inc. 0832-6054
NorepinephrineMakes it Breckenridge Pharmaceutical, Inc. 51991-983

FDA inspection history

EndedResultProgramProblems noted
Jun 21, 2024Problems found, fixed voluntarilyDrug Quality Assurance—
May 19, 2023No problems foundBioresearch Monitoring—
Jun 4, 2021Problems found, fixed voluntarilyDrug Quality Assurance—
Mar 11, 2020No problems foundBioresearch Monitoring—
May 31, 2018Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: manufacture.